Cargando…

Giant osteoclasts in patients under bisphosphonates

BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mac-Way, Fabrice, Trombetti, Andrea, Noel, Christian, Lafage-Proust, Marie-Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094788/
https://www.ncbi.nlm.nih.gov/pubmed/25024641
http://dx.doi.org/10.1186/1472-6890-14-31
_version_ 1782325902304083968
author Mac-Way, Fabrice
Trombetti, Andrea
Noel, Christian
Lafage-Proust, Marie-Hélène
author_facet Mac-Way, Fabrice
Trombetti, Andrea
Noel, Christian
Lafage-Proust, Marie-Hélène
author_sort Mac-Way, Fabrice
collection PubMed
description BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. CASE PRESENTATION: We describe in this paper two patients treated with bisphosphonates from whom iliac crest bone biopsies have shown large, multinucleated and apoptotic osteoclasts that were not associated with bone resorption activities. The characteristics of these osteoclasts are described and the literature reviewed. CONCLUSION: The appropriate recognition of these giant osteoclasts in bone tissues from patients treated with bisphosphonates is of primary importance for bone pathologists and should not be interpreted as signs of increased bone resorption as seen in hyperparathyroidism, bone cancer or Paget’s disease of bone.
format Online
Article
Text
id pubmed-4094788
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40947882014-07-15 Giant osteoclasts in patients under bisphosphonates Mac-Way, Fabrice Trombetti, Andrea Noel, Christian Lafage-Proust, Marie-Hélène BMC Clin Pathol Case Report BACKGROUND: Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. CASE PRESENTATION: We describe in this paper two patients treated with bisphosphonates from whom iliac crest bone biopsies have shown large, multinucleated and apoptotic osteoclasts that were not associated with bone resorption activities. The characteristics of these osteoclasts are described and the literature reviewed. CONCLUSION: The appropriate recognition of these giant osteoclasts in bone tissues from patients treated with bisphosphonates is of primary importance for bone pathologists and should not be interpreted as signs of increased bone resorption as seen in hyperparathyroidism, bone cancer or Paget’s disease of bone. BioMed Central 2014-07-08 /pmc/articles/PMC4094788/ /pubmed/25024641 http://dx.doi.org/10.1186/1472-6890-14-31 Text en Copyright © 2014 Mac-Way et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Mac-Way, Fabrice
Trombetti, Andrea
Noel, Christian
Lafage-Proust, Marie-Hélène
Giant osteoclasts in patients under bisphosphonates
title Giant osteoclasts in patients under bisphosphonates
title_full Giant osteoclasts in patients under bisphosphonates
title_fullStr Giant osteoclasts in patients under bisphosphonates
title_full_unstemmed Giant osteoclasts in patients under bisphosphonates
title_short Giant osteoclasts in patients under bisphosphonates
title_sort giant osteoclasts in patients under bisphosphonates
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094788/
https://www.ncbi.nlm.nih.gov/pubmed/25024641
http://dx.doi.org/10.1186/1472-6890-14-31
work_keys_str_mv AT macwayfabrice giantosteoclastsinpatientsunderbisphosphonates
AT trombettiandrea giantosteoclastsinpatientsunderbisphosphonates
AT noelchristian giantosteoclastsinpatientsunderbisphosphonates
AT lafageproustmariehelene giantosteoclastsinpatientsunderbisphosphonates